Abstract:Abstract Background Liver ischemia/reperfusion (I/R) injury is an inevitable pathological phenomenon in various clinical conditions, such as liver transplantation, resection surgery, or shock, which is the major cause of morbidity and mortality after operation. Ginkgo Biloba Dropping Pill (GBDP) is a unique Chinese Ginkgo Biloba leaf extract preparation that exhibits a variety of beneficial biological activities. The aim of this study is to investigate the protective effects of GBDP on the liver I/R injury both in the in vitro and in vivo. Methods Hypoxia/reoxygenation (H/R) experiments were performed in alpha mouse liver 12 (AML-12) cells and primary hepatocytes, which were pretreated with GBDP (60 or 120 µg/mL) followed by incubation in a hypoxia chamber. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay. Annexin V staining as well as western blot analysis of apoptosis-related proteins was performed to detect the protective effect of GBDP on cell apoptosis induced by H/R injury. C57BL/6 mice were used to establish the liver I/R injury model, and were pretreated with GBDP (100 or 200 mg/kg/day, i.g.) for two weeks. The liver damage was evaluated by detection of plasma levels of alanine transaminase (ALT) and aspartate transaminase (AST), as well as histopathological examinations. Liver inflammation was determined by detecting the secretion of pro-inflammatory cytokines and neutrophil infiltration through enzyme-linked immunosorbent assay (ELISA) and myeloperoxidase (MPO) immunohistochemistry staining. Finally, Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick and labeling (TUNEL) staining and western blot analysis of apoptosis-related proteins were used to investigate the anti-apoptotic effect of GBDP in mice. Results In the in vitro study, GBDP pretreatment improved the cell viability of AML-12 cells in the H/R injury model. Similarly, the same result was found in the primary hepatocytes isolated from C57BL/6 mice. Moreover, GBDP decreased the number of apoptotic cells and reduced the expression of apoptosis-related proteins induced by H/R injury. In the in vivo study, oral administration of GBDP ameliorated liver injury evidenced by a significant decline in the levels of ALT and AST. Furthermore, the result of hematoxylin and eosin (H&E) staining showed that GBDP reduced the size of necrosis area in the liver tissue. In addition, the decreased infiltration of neutrophils and secretion of pro-inflammatory cytokines indicated that GBDP may play an anti-inflammatory effect. More importantly, GBDP reduced TUNEL-positive cells and the expression of apoptosis-related proteins in the liver indicating GBDP has anti-apoptotic effects. Conclusions Our findings elucidated that GBDP has potential effects for protecting against liver I/R injury characterized by its anti-apoptotic, anti-necrotic, and anti-inflammatory properties, which would promisingly make contributions to the exploration of therapeutic strategies in the liver I/R injury.

Effect of Ginkgo Biloba Extract on the Expressions of Cox-2 and GST-Pi in Rats with Hepatocellular Carcinoma Risk.

Effects of Ginkogo Biloba on the Expression of IGF-Ⅱ Mrna and Protein During Hepatocarcinogenesis Aflatoxin B1-induced in Wistar Rats

Effects of emodin and astragalus polysaccharides on the expressions of GST-P and TGF-β_1 in rats' hepatocellular carcinoma constitution

Effects of Ginkgo Extract on the Activity of CYP4A4 During Hepatocarcinogenesis Induced by AFB1 in Wistar Rats

Chemoprevention of aflatoxin B_1-induced hepatic oxidative damage and hepatocarcinogenesis in rats by Ginkgo biloba extract EGb 761

Effects of Ginkgo Biloba Extract on Biomarker Expressions During Aflatoxin B1-induced Hepatocarcinogenesis in Wistar Rats.

Effects of Ginkgo Biloba Extracts (gbe) on Cyclooxygenase-2 in Liver of Rats with Hepatic Fibrosis

Prevented effect of Ginkgo Biloba extract an liver fibrosis of rat

Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats.

Effects of Ginkgo biloba extract on expression of NF-κB in rat liver fibrosis

[Effects of Nuclear Factor Kappab and Transforming Growth Factor Beta1 in the Anti-Liver Fibrosis Process Using Ginkgo Biloba Extract].

Therapeutic Effects and Molecular Mechanisms of Ginkgo Biloba Extract on Liver Fibrosis in Rats

Protective Effects of Ginkgo Biloba Dropping Pills Against Liver Ischemia/reperfusion Injury in Mice

[Ginkgo Biloba Extracts (egb761) Inhibits Aflatoxin B1-induced Hepatocarcinogenesis in Wistar Rats].

The effect of fibronectin and arginine-glycine-aspartic-serine tetrepeptide on chemotherapy sensitivity of liver carcinoma cell lines

Effect of ginkgo biloba extract on expression of Activin A in hepatic fibrosis of rat.

Effects of Extract from Ginkgo Biloba on Carbon Tetrachloride-Induced Liver Injury in Rats

Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways

Effect of Ginkgo Bibloba Extract on Transforming Growth Factor-Β1 and Collagen Type Ⅰ in Hepatic Tissues of Experimental Hepatofibrosis Rats

In Vitro Regulation of Hepatocellular Carcinoma Cell Viability, Apoptosis, Invasion, and AEG-1 Expression by LY294002

Antitumor Effect of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Combined with Cytotoxic Agent on Murine Hepatocellular Carcinoma